rfhg_106296.1

Basic information about the TSS

---

TSS ID: rfhg_106296.1 Species: human Chr: chr8		Start: 43056410 End: 43056456 Strand: +
Source datasets	PRJDB5282|PRJNA401781|PRJNA548673|PRJNA615891
Protocol	C1CAGE|CAGE|oligo_capping|RAMPAGE|ReCappable-seq|SLIC_CAGE |TIF-seq2
TSS cluster detected*	8

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	-
Category:	-

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000533368.1:0 GeneID: 2339 HGNC/MGI_ID: HGNC:3782 UniProt_ID: Nearer transcript ids and distances: ENST00000531266.5:-48 BC017029:-54 ENST00000524546.5:-55 AB590505:-63 KJ891191:-63 BT009854:-63 L10413:-69 BC084566:-71 L00634:-77 KJ905747:78 ENST00000533998.5:-79 ENST00000533383.5:-80 ENST00000527153.5:-82 ENST00000302279.8:-87 NM_002027.3:-87 NR_033698.2:-87 AK292121:-87 ENST00000526755.5:-102 BC037295:-102 ENST00000525699.5:136 ENST00000529687.5:217 AK123002:217 view more...

Gene_name: farnesyltransferase, CAAX box, alpha Gene_symbol: FNTA Gene_synonyms: FPTA PGGT1A PTAR2 Gene_source: HGNC:3782

TATA-Box annotation

---

Distance to TSS:	110
Nearest PromoterID:	NM_002027
Entrez ID:	2339
Nearest Unigene:	Hs.370312
Nearest Refseq:	NM_002027
Nearest Ensembl:	ENSG00000168522
Gene Name:	farnesyltransferase, CAAX box, alpha
Gene Alias:	FPTA|PGGT1A|PTAR2
Gene Type:	protein-coding
CpG%:	0.086957
GC%:	0.787234
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@FNTA p2@FNTA
Sample		p1@FNTA	p2@FNTA
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	34.29	2.14
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	33.99	2.63
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	37.81	4.05
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	30.35	2.91
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	35.32	3.15
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	32.95	3.68
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	34.21	3.49
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	35.61	2.66
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	33.55	3.21
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	53.33	6.96
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	42.85	3.64
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	56.10	3.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	39.65	1.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	29.92	2.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	41.28	2.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	31.69	2.51
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	31.67	2.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	35.43	2.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	29.32	1.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	32.19	2.86
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	39.69	2.14
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	36.60	2.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	38.52	2.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	32.03	2.91
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	32.76	5.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	33.87	3.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	34.62	1.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	41.73	3.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	37.47	1.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	35.47	2.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	36.22	3.14
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	30.67	2.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	35.24	2.74
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	38.93	2.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	32.16	2.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	33.73	2.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	30.45	3.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	30.63	2.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	33.22	3.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	29.29	4.08
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	28.47	2.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	32.35	3.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	25.10	2.74
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	34.09	3.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	27.10	3.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	30.48	4.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	28.55	3.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	31.59	2.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	24.89	5.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	24.67	3.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	27.67	2.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	22.24	3.11
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	153.91	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	25.55	3.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	21.21	1.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	33.56	7.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	27.10	3.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	14.26	1.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	20.88	2.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	18.55	4.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	25.38	2.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	26.36	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	31.85	2.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	20.05	2.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	15.92	3.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	15.62	2.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	96.98	16.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	126.36	39.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	20.48	1.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	12.40	3.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	15.95	1.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	16.56	2.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	16.40	1.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	19.57	2.75
Adipocyte - breast, donor1	11376-118A8	31.84	4.12
Adipocyte - breast, donor2	11327-117E4	36.90	3.21
Adipocyte - omental, donor1	11473-119C6	34.22	3.05
Adipocyte - omental, donor2	11474-119C7	30.65	2.24
Adipocyte - omental, donor3	11475-119C8	27.46	2.01
Adipocyte - perirenal, donor1	11476-119C9	25.52	2.55
Adipocyte - subcutaneous, donor1	11259-116F8	9.90	1.10
Adipocyte - subcutaneous, donor2	11336-117F4	30.71	1.81
Adipocyte - subcutaneous, donor3	11408-118E4	40.84	1.56
Adipocyte differentiation, day04, donor1	13019-139D4	35.40	2.54
Adipocyte differentiation, day04, donor2	13022-139D7	27.02	1.54
Adipocyte differentiation, day04, donor3	13025-139E1	34.01	1.95
Adipocyte differentiation, day04, donor4	13028-139E4	39.97	2.35
Adipocyte differentiation, day08, donor1	13020-139D5	39.25	2.01
Adipocyte differentiation, day08, donor2	13023-139D8	30.98	1.94
Adipocyte differentiation, day08, donor3	13026-139E2	30.92	1.60
Adipocyte differentiation, day08, donor4	13029-139E5	25.04	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	33.27	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	31.40	1.00
Adipocyte differentiation, day12, donor3	13027-139E3	30.11	0.98
Adipocyte differentiation, day12, donor4	13030-139E6	26.18	1.22
Alveolar Epithelial Cells, donor1	11510-119G7	13.70	0.66
Alveolar Epithelial Cells, donor2	11590-120G6	3.59	0.36
Alveolar Epithelial Cells, donor3	11671-122G6	3.59	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	22.49	1.26
Amniotic Epithelial Cells, donor2	11613-122A2	13.39	1.67
Amniotic Epithelial Cells, donor3	11694-123A2	15.61	1.23
Anulus Pulposus Cell, donor1	11248-116E6	51.26	2.40
Anulus Pulposus Cell, donor2	11463-119B5	35.51	2.94
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	33.25	4.04
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	35.17	1.74
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	34.24	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	33.78	1.49
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	22.76	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	22.44	3.30
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	32.49	2.27
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	33.01	2.43
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	24.94	1.19
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	29.38	2.64
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	26.12	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	21.31	1.25
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	28.66	2.97
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	34.12	1.36
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	22.02	1.66
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	31.08	3.21
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	26.26	0.94
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	25.12	3.47
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	26.34	1.95
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	26.70	2.65
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	14.41	3.60
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	42.48	3.54
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	29.67	1.72
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	16.78	4.19
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	37.38	2.43
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	30.36	1.52
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	21.80	2.42
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	33.06	3.99
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	26.29	0.86
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	21.68	2.06
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	28.15	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	30.23	1.93
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	19.98	0.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	29.25	2.34
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	28.60	1.20
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	23.76	3.56
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	36.11	3.05
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	20.38	1.53
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	17.79	2.54
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	35.82	1.73
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	27.94	2.54
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	26.68	2.32
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	36.84	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	28.82	1.70
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	16.21	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	38.03	4.23
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	31.95	1.29
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	18.05	1.80
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	40.09	1.46
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	29.19	2.30
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	20.40	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	24.41	2.29
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	27.66	3.92
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	17.44	1.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	37.28	1.43
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	33.26	3.99
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	16.78	1.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	27.14	4.43
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	26.74	1.85
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	19.63	2.18
Astrocyte - cerebellum, donor1	11500-119F6	16.21	1.35
Astrocyte - cerebellum, donor2	11580-120F5	10.44	0.17
Astrocyte - cerebellum, donor3	11661-122F5	6.08	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	52.64	5.58
Astrocyte - cerebral cortex, donor2	11316-117D2	36.08	5.01
Astrocyte - cerebral cortex, donor3	11392-118C6	44.30	3.73
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	66.40	4.82
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	59.51	5.39
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	66.00	6.94
Basophils, donor1	12241-129G9	20.14	0.52
Basophils, donor2	12242-129H1	33.91	2.53
Basophils, donor3	12243-129H2	30.13	1.03
Bronchial Epithelial Cell, donor1	11511-119G8	11.64	0.43
Bronchial Epithelial Cell, donor2	11591-120G7	8.69	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	43.04	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	25.11	2.51
Bronchial Epithelial Cell, donor5	11457-119A8	14.56	2.50
Bronchial Epithelial Cell, donor6	11461-119B3	32.01	4.38
Bronchial Epithelial Cell, donor7	11769-123I5	37.97	0.90
Burkitt's lymphoma cell line:DAUDI	10422-106C8	78.01	7.32
Burkitt's lymphoma cell line:RAJI	10476-106I8	40.76	4.19
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	55.64	13.11
CD133+ stem cells - cord blood derived, pool1	12223-129E9	82.74	20.68
CD14+ Monocytes, donor1	11224-116B9	24.23	1.13
CD14+ Monocytes, donor2	11305-117B9	25.80	1.67
CD14+ Monocytes, donor3	11381-118B4	25.25	2.63
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	69.63	1.42
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	60.27	3.41
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	65.42	2.96
CD14+ monocytes - mock treated, donor1	11863-125A9	45.97	2.75
CD14+ monocytes - mock treated, donor2	11873-125C1	44.36	2.11
CD14+ monocytes - mock treated, donor3	11883-125D2	57.56	1.90
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	23.10	1.17
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	29.53	1.93
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	22.81	1.49
CD14+ monocytes - treated with BCG, donor1	11860-125A6	15.47	0.78
CD14+ monocytes - treated with BCG, donor2	11870-125B7	23.15	0.36
CD14+ monocytes - treated with BCG, donor3	11880-125C8	20.24	0.87
CD14+ monocytes - treated with Candida, donor1	11868-125B5	17.09	1.64
CD14+ monocytes - treated with Candida, donor2	11878-125C6	27.99	1.58
CD14+ monocytes - treated with Candida, donor3	11888-125D7	27.73	2.22
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	31.24	1.19
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	28.54	2.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	33.94	2.08
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	17.62	0.69
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	18.77	1.13
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	13.97	0.44
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	28.51	1.88
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	37.51	2.79
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	32.40	2.52
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	14.70	1.29
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	14.44	0.35
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	20.62	0.44
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	22.32	0.35
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	23.79	0.74
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	27.59	1.51
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	22.93	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	14.37	0.70
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	17.86	0.23
CD14+CD16+ Monocytes, donor1	11789-124B7	49.91	1.53
CD14+CD16+ Monocytes, donor2	11801-124D1	45.51	2.77
CD14+CD16+ Monocytes, donor3	11912-125G4	49.82	3.03
CD14+CD16- Monocytes, donor1	11788-124B6	64.00	1.56
CD14+CD16- Monocytes, donor2	11799-124C8	60.60	1.75
CD14+CD16- Monocytes, donor3	11910-125G2	63.55	2.45
CD14-CD16+ Monocytes, donor1	11790-124B8	41.59	4.08
CD14-CD16+ Monocytes, donor2	11800-124C9	49.62	3.07
CD14-CD16+ Monocytes, donor3	11911-125G3	53.27	2.53
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	132.10	6.10
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	128.14	6.10
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	130.49	3.11
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	99.15	3.73
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	128.12	3.75
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	105.29	4.21
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	122.36	6.27
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	123.92	1.32
CD19+ B Cells, donor1	11544-120B5	61.64	5.75
CD19+ B Cells, donor2	11624-122B4	63.84	3.63
CD19+ B Cells, donor3	11705-123B4	56.04	3.03
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	39.19	2.83
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	38.35	1.60
CD34+ Progenitors, donor1	11545-120B6	51.21	3.01
CD34+ Progenitors, donor2	11625-122B5	35.96	4.49
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	58.99	8.64
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	57.27	9.92
CD4+ T Cells, donor1	11225-116C1	87.84	5.36
CD4+ T Cells, donor2	11306-117C1	75.93	4.90
CD4+ T Cells, donor3	11382-118B5	50.32	2.44
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	110.26	4.85
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	92.98	1.57
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	104.92	3.16
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	113.31	3.32
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	151.70	3.51
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	115.37	3.30
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	72.84	2.75
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	66.43	2.03
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	64.97	2.26
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	87.87	2.69
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	100.97	2.10
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	87.12	2.64
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	93.60	2.95
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	66.69	2.49
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	55.80	2.34
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	102.79	2.99
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	161.32	6.43
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	111.18	3.59
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	96.42	2.41
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	76.68	2.60
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	78.18	2.31
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	85.95	2.53
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	86.22	3.47
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	98.06	3.05
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	168.75	4.45
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	135.71	1.85
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	163.31	8.37
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	142.34	4.98
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	166.38	5.64
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	155.54	9.24
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	131.07	4.66
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	144.04	8.31
CD8+ T Cells, donor1	11226-116C2	61.22	4.91
CD8+ T Cells, donor2	11307-117C2	47.30	3.00
CD8+ T Cells, donor3	11383-118B6	69.94	6.31
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	28.22	1.84
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	22.29	2.40
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	21.07	1.64
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	16.51	3.90
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	27.84	3.36
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	25.24	2.96
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	25.20	2.39
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	26.06	2.11
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	19.00	2.35
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	23.85	3.62
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	22.37	2.91
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	25.31	3.20
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	30.64	2.63
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	25.96	1.37
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	31.33	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	36.02	4.68
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	30.21	1.73
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	25.46	1.41
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	27.57	2.22
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	25.53	4.31
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	26.93	4.49
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	26.01	5.35
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	20.49	2.76
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	29.50	1.51
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	81.10	6.42
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	67.84	9.09
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	84.15	7.01
Cardiac Myocyte, donor1	11525-119I4	124.29	1.83
Cardiac Myocyte, donor2	11605-120I3	43.97	3.46
Cardiac Myocyte, donor3	11686-122I3	34.73	6.00
Chondrocyte - de diff, donor1	11261-116G1	18.37	1.04
Chondrocyte - de diff, donor2	11338-117F6	35.54	2.13
Chondrocyte - de diff, donor3	11410-118E6	32.65	2.16
Chondrocyte - re diff, donor2	11339-117F7	64.46	3.58
Chondrocyte - re diff, donor3	11411-118E7	33.57	2.02
Ciliary Epithelial Cells, donor1	11242-116D9	50.38	5.62
Ciliary Epithelial Cells, donor2	11323-117D9	35.27	4.70
Ciliary Epithelial Cells, donor3	11399-118D4	41.77	3.54
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	47.50	3.48
Corneal Epithelial Cells, donor1	11526-119I5	6.81	0.44
Corneal Epithelial Cells, donor2	11606-120I4	12.51	1.14
Corneal Epithelial Cells, donor3	11687-122I4	12.53	0.77
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	44.08	12.88
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	51.10	15.14
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	55.21	20.70
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	48.38	4.97
Dendritic Cells - plasmacytoid, donor1	11228-116C4	44.07	9.22
Dendritic Cells - plasmacytoid, donor2	11309-117C4	44.40	11.75
Dendritic Cells - plasmacytoid, donor3	11385-118B8	49.85	5.81
Endothelial Cells - Aortic, donor0	11207-116A1	30.19	2.17
Endothelial Cells - Aortic, donor1	11263-116G3	26.40	0.59
Endothelial Cells - Aortic, donor2	11340-117F8	24.60	1.13
Endothelial Cells - Aortic, donor3	11412-118E8	26.34	1.97
Endothelial Cells - Artery, donor1	11264-116G4	22.40	2.33
Endothelial Cells - Artery, donor2	11341-117F9	25.41	1.65
Endothelial Cells - Artery, donor3	11413-118E9	30.33	1.93
Endothelial Cells - Lymphatic, donor1	11236-116D3	42.56	2.66
Endothelial Cells - Lymphatic, donor2	11317-117D3	46.86	4.26
Endothelial Cells - Lymphatic, donor3	11393-118C7	46.80	1.97
Endothelial Cells - Microvascular, donor1	11265-116G5	16.94	0.30
Endothelial Cells - Microvascular, donor2	11342-117G1	34.36	2.60
Endothelial Cells - Microvascular, donor3	11414-118F1	24.53	0.99
Endothelial Cells - Thoracic, donor1	11266-116G6	43.21	3.60
Endothelial Cells - Thoracic, donor2	11343-117G2	26.73	0.52
Endothelial Cells - Umbilical vein, donor1	11243-116E1	70.07	3.73
Endothelial Cells - Umbilical vein, donor2	11324-117E1	50.40	1.09
Endothelial Cells - Umbilical vein, donor3	11400-118D5	54.35	1.34
Endothelial Cells - Vein, donor1	11267-116G7	32.99	1.14
Endothelial Cells - Vein, donor2	11344-117G3	25.84	1.40
Endothelial Cells - Vein, donor3	11416-118F3	43.33	2.36
Eosinophils, donor1	12244-129H3	15.25	0.00
Eosinophils, donor2	12245-129H4	36.31	4.95
Eosinophils, donor3	12246-129H5	24.97	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	8.06	0.49
Esophageal Epithelial Cells, donor2	11587-120G3	8.32	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	32.54	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	27.09	5.34
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	17.74	1.42
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	25.24	3.36
Fibroblast - Aortic Adventitial, donor1	11245-116E3	28.62	4.24
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	35.89	2.59
Fibroblast - Aortic Adventitial, donor2	11326-117E3	25.10	3.16
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	27.14	2.37
Fibroblast - Aortic Adventitial, donor3	11401-118D6	29.90	2.66
Fibroblast - Cardiac, donor1	11268-116G8	29.94	4.08
Fibroblast - Cardiac, donor2	11345-117G4	19.71	0.00
Fibroblast - Cardiac, donor3	11417-118F4	16.40	2.37
Fibroblast - Cardiac, donor4	11452-119A3	47.28	4.55
Fibroblast - Cardiac, donor5	11456-119A7	48.10	6.35
Fibroblast - Cardiac, donor6	11460-119B2	35.02	6.22
Fibroblast - Choroid Plexus, donor1	11492-119E7	20.37	2.01
Fibroblast - Choroid Plexus, donor2	11572-120E6	49.18	4.75
Fibroblast - Choroid Plexus, donor3	11653-122E6	27.83	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	19.83	0.69
Fibroblast - Conjunctival, donor3	11692-122I9	57.33	6.28
Fibroblast - Dermal, donor1	11269-116G9	47.43	3.05
Fibroblast - Dermal, donor2	11346-117G5	41.98	3.30
Fibroblast - Dermal, donor3	11418-118F5	45.57	4.71
Fibroblast - Dermal, donor4	11450-119A1	28.49	3.62
Fibroblast - Dermal, donor5	11454-119A5	33.50	3.31
Fibroblast - Dermal, donor6	11458-119A9	34.27	2.27
Fibroblast - Gingival, donor1	11237-116D4	45.81	3.96
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	34.85	3.41
Fibroblast - Gingival, donor2	11318-117D4	35.45	2.90
Fibroblast - Gingival, donor3	11394-118C8	56.47	2.13
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	29.09	3.12
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	24.67	2.29
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	32.11	2.34
Fibroblast - Gingival, donor6 (control)	11922-125H5	26.64	2.84
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	15.88	2.12
Fibroblast - Gingival, donor7 (control)	11924-125H7	29.40	4.68
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	23.32	2.86
Fibroblast - Gingival, donor8 (control)	11926-125H9	24.79	3.95
Fibroblast - Gingival, donor9 (control)	11927-125I1	39.62	4.11
Fibroblast - Lung, donor1	11270-116H1	16.31	0.00
Fibroblast - Lung, donor2	11347-117G6	35.81	0.00
Fibroblast - Lung, donor3	11419-118F6	28.49	2.74
Fibroblast - Lymphatic, donor1	11506-119G3	10.83	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	11.19	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	3.36	0.56
Fibroblast - Mammary, donor1	11540-120B1	19.49	1.22
Fibroblast - Mammary, donor2	11620-122A9	3.99	0.00
Fibroblast - Mammary, donor3	11701-123A9	23.83	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	39.76	1.55
Fibroblast - Periodontal Ligament, donor2	11319-117D5	39.74	2.12
Fibroblast - Periodontal Ligament, donor3	11395-118C9	43.76	1.22
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	27.10	0.76
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	22.68	1.89
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	24.93	2.55
Fibroblast - Pulmonary Artery, donor1	11250-116E8	32.61	4.97
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	14.22	1.22
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	10.02	0.67
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	30.05	4.74
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	36.91	2.38
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	38.72	3.02
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	37.05	3.15
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	34.60	1.50
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	34.44	1.51
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	38.47	3.04
Fibroblast - skin normal, donor1	11553-120C5	36.59	1.64
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	31.88	4.61
Fibroblast - skin normal, donor2	11561-120D4	30.54	3.21
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	40.80	3.63
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	46.23	3.81
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	57.27	1.54
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	20.03	1.97
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	30.04	2.13
Fibroblast - skin walker warburg, donor1	11554-120C6	24.96	3.71
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	26.50	2.98
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	110.80	22.16
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	62.75	5.23
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	47.85	6.07
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	48.67	4.94
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	40.63	4.60
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	47.46	11.48
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	44.03	11.49
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	43.93	5.99
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	68.66	4.69
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	53.43	7.31
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	47.95	1.98
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	52.87	5.82
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	51.53	5.54
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	37.59	6.19
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	62.89	5.79
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	56.03	5.17
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	46.20	5.64
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	63.68	4.46
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	59.94	3.88
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	40.25	3.66
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	50.88	3.88
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	63.65	3.24
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	61.64	2.19
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	52.60	4.43
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	51.03	3.50
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	45.13	2.90
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	44.56	4.03
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	46.82	5.60
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	50.10	6.74
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	52.86	6.87
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	58.23	5.98
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	52.78	5.09
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	46.59	5.49
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	46.76	5.51
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	50.75	4.33
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	52.69	4.61
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	45.86	5.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	44.31	3.53
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	52.89	4.55
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	43.44	5.67
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	48.43	5.13
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	45.29	3.60
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	42.07	3.95
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	35.88	2.74
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	40.56	3.97
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	43.69	3.51
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	36.47	1.40
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	29.54	2.96
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	34.23	2.67
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	31.67	3.83
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	31.61	4.66
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	38.49	2.17
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	29.31	2.95
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	33.99	3.07
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	24.79	1.98
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	31.00	3.30
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	33.29	2.82
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	42.95	4.57
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	60.32	5.18
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	63.79	3.24
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	73.85	6.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	33.48	5.01
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	37.86	5.93
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	51.19	6.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	69.29	7.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	45.64	7.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	41.72	3.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	73.03	6.96
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	63.79	6.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	53.53	4.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	39.99	3.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	54.25	3.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	46.74	4.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	51.17	5.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	64.57	6.04
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	54.69	4.76
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	71.00	8.35
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	69.30	4.01
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	37.29	0.89
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	62.68	3.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	60.47	9.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	58.91	7.13
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	63.22	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	56.89	5.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	59.98	4.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	72.23	6.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	96.32	6.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	85.58	8.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	77.03	7.45
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	79.27	3.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	81.47	2.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	84.44	5.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	70.59	4.79
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	76.96	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	59.02	5.90
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	77.01	2.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	85.58	4.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	50.01	4.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	46.56	7.76
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	37.36	11.16
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	9.13	2.28
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	16.63	0.83
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	22.49	3.37
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	38.69	2.22
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	40.94	2.51
Hep-2 cells mock treated, biol_rep1	11898-125E8	34.46	4.18
Hep-2 cells mock treated, biol_rep2	11899-125E9	42.88	4.73
Hep-2 cells mock treated, biol_rep3	11900-125F1	37.99	4.10
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	36.40	5.25
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	36.75	5.16
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	30.79	4.31
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	35.49	4.23
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	27.62	3.60
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	28.83	3.20
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	21.27	1.12
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	8.66	0.43
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	15.86	2.64
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	12.35	1.06
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	10.17	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	22.73	2.97
Hepatocyte, donor1	11523-119I2	35.11	1.21
Hepatocyte, donor2	11603-120I1	88.34	1.08
Hepatocyte, donor3	11684-122I1	38.04	1.23
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	76.36	8.48
Intestinal epithelial cells (polarized), donor1	11246-116E4	60.65	7.17
Iris Pigment Epithelial Cells, donor1	11530-119I9	29.23	3.02
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	25.47	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	46.73	6.68
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	54.17	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	35.99	2.77
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	12.51	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	23.74	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	25.63	5.13
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	45.71	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	40.61	3.25
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	51.69	5.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	54.46	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	25.15	2.65
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	34.37	3.33
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	41.91	15.71
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	27.08	4.41
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	30.93	3.09
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	14.63	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	33.59	2.58
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	32.20	3.22
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	35.84	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	39.93	0.81
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	27.29	2.10
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	14.37	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	41.79	4.82
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	30.47	3.69
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	30.16	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	24.07	2.36
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	19.05	8.16
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	44.23	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	34.44	3.23
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	35.57	2.54
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	49.29	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	31.25	1.91
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	45.57	1.82
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	31.61	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	28.56	2.14
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	29.86	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	29.01	4.01
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	24.58	1.76
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	22.00	3.14
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	31.99	0.70
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	35.41	8.85
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	42.15	3.24
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	28.77	1.74
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	36.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	20.91	3.48
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	27.74	2.13
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	30.48	1.39
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	25.65	2.85
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	30.37	6.44
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	18.15	6.05
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	31.04	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	21.15	0.00
Keratinocyte - epidermal, donor1	11272-116H3	24.32	2.61
Keratinocyte - epidermal, donor2	11349-117G8	31.04	1.76
Keratinocyte - epidermal, donor3	11421-118F8	41.84	4.45
Keratinocyte - oral, donor1	11251-116E9	69.59	4.65
Keratocytes, donor1	11527-119I6	22.01	1.72
Keratocytes, donor2	11607-120I5	5.86	1.17
Keratocytes, donor3	11688-122I5	48.81	2.96
Krukenberg tumor cell line:HSKTC	10687-109F3	10.99	0.00
Lens Epithelial Cells, donor1	11529-119I8	35.60	3.24
Lens Epithelial Cells, donor2	11609-120I7	46.71	1.96
Lens Epithelial Cells, donor3	11690-122I7	39.15	3.53
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	32.37	1.90
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	28.74	0.56
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	42.97	2.52
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	32.26	1.61
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	29.00	0.63
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	28.57	0.97
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	40.63	3.28
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	16.69	1.26
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	24.21	1.13
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	39.95	4.75
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	31.99	1.55
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	16.66	0.74
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	36.93	3.14
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	29.34	0.72
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	21.29	0.55
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	40.65	3.70
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	20.89	1.25
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	24.89	1.28
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	28.30	1.97
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	18.45	1.17
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	19.91	1.24
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	29.58	3.39
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	28.55	2.69
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	29.67	1.97
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	30.07	1.04
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	33.71	1.68
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	26.62	1.80
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	39.21	4.82
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	30.67	2.07
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	21.10	2.12
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	44.10	1.45
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	31.76	2.32
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	19.70	1.24
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	40.72	1.85
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	29.16	0.99
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	18.97	0.82
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	41.49	2.57
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	42.00	3.35
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	36.25	2.24
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	39.82	3.20
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	17.45	0.48
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	15.41	0.93
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	34.38	2.86
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	29.07	5.23
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	13.65	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	31.43	3.47
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	23.05	0.77
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	24.76	1.19
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	11.33	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	15.34	2.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	13.36	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	9.73	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	3.52	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	13.08	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	10.31	0.52
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	21.41	1.19
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	15.38	1.58
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	12.80	1.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	16.21	1.35
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	13.41	0.27
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	11.30	0.51
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	13.06	1.76
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	9.33	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	14.77	0.51
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	16.28	1.87
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	14.36	0.94
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	16.57	1.23
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	17.12	1.63
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	12.49	0.83
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	12.61	1.40
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	15.46	2.06
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	15.39	0.29
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	10.46	0.30
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	17.15	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	18.38	0.35
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	14.01	0.37
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	13.82	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	13.43	1.54
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	7.93	2.26
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	13.95	0.82
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	16.27	1.36
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	10.05	1.44
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	17.93	2.24
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	15.61	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	13.35	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	12.84	1.71
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	15.66	1.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	14.48	0.60
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	10.66	2.13
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	10.66	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	12.35	0.54
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	19.53	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	15.56	1.11
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	18.61	1.16
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	17.98	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	22.81	1.20
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	14.54	2.18
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	13.03	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	13.32	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	14.11	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	14.08	2.51
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	13.52	1.35
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	6.88	1.72
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	12.47	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	15.64	0.39
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	13.19	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	12.97	1.56
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	22.75	1.31
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	16.21	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	15.46	2.21
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	15.43	0.39
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	15.70	1.52
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	13.94	1.92
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	14.71	1.59
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	11.54	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	9.68	2.77
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	17.10	0.76
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	11.36	2.58
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	14.51	1.81
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	17.11	0.95
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	17.59	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	16.09	1.15
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	12.86	0.51
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	14.15	1.41
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	14.75	1.13
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	12.06	0.83
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	14.88	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	10.44	1.25
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	19.51	1.39
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	10.70	1.34
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	10.16	0.53
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	16.16	0.40
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	7.34	1.84
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	15.11	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	12.54	1.71
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	12.27	0.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	9.85	2.19
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	12.47	0.45
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	14.30	2.08
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	12.60	0.66
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	14.55	0.00
Macrophage - monocyte derived, donor1	11232-116C8	49.23	4.56
Macrophage - monocyte derived, donor2	11313-117C8	26.24	6.97
Macrophage - monocyte derived, donor3	11389-118C3	40.64	3.15
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	48.32	7.43
Mallassez-derived cells, donor2	11929-125I3	48.96	3.64
Mallassez-derived cells, donor3	11930-125I4	50.87	5.84
Mammary Epithelial Cell, donor1	11273-116H4	82.50	11.16
Mammary Epithelial Cell, donor2	11350-117G9	53.57	4.92
Mammary Epithelial Cell, donor3	11422-118F9	30.68	1.50
Mast cell - stimulated, donor1	11487-119E2	38.64	14.24
Mast cell, donor1	11563-120D6	52.56	5.62
Mast cell, donor2	11565-120D8	52.01	4.16
Mast cell, donor3	11566-120D9	54.93	3.83
Mast cell, donor4	11567-120E1	47.87	5.50
Mast cell, expanded and stimulated, donor5	11940-126A5	52.12	3.11
Mast cell, expanded and stimulated, donor8	11942-126A7	37.36	8.17
Mast cell, expanded, donor5	11939-126A4	50.82	2.87
Mast cell, expanded, donor8	11941-126A6	44.85	3.68
Melanocyte - dark, donor1	11502-119F8	52.34	2.39
Melanocyte - dark, donor2	11582-120F7	32.88	2.77
Melanocyte - dark, donor3	11663-122F7	34.12	4.20
Melanocyte - light, donor1	11274-116H5	14.34	0.71
Melanocyte - light, donor2	11351-117H1	17.74	0.00
Melanocyte - light, donor3	11423-118G1	23.42	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	31.03	3.75
Melanocyte, donor2 (MC+2)	12739-135I3	29.05	4.30
Melanocyte, donor3 (MC+3)	12837-137B2	35.89	1.87
Meningeal Cells, donor1	11493-119E8	19.60	2.36
Meningeal Cells, donor2	11573-120E7	23.33	4.84
Meningeal Cells, donor3	11654-122E7	36.11	6.36
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	46.48	4.85
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	29.99	2.11
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	6.57	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	9.16	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	38.75	2.15
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	26.47	2.75
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	24.63	2.01
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	13.84	0.66
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	13.15	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	12.89	0.61
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	42.11	2.08
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	14.13	1.12
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	49.34	4.61
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	14.24	0.59
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	11.68	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	8.97	1.28
Mesenchymal stem cells - adipose, donor0	11217-116B2	46.79	3.19
Mesenchymal stem cells - hepatic, donor0	11218-116B3	53.48	4.07
Mesenchymal stem cells - umbilical, donor0	11214-116A8	32.66	1.45
Mesothelial Cells, donor1	11247-116E5	34.74	2.12
Mesothelial Cells, donor2	12156-128G5	26.02	0.50
Mesothelial Cells, donor3	11402-118D7	27.61	2.89
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	28.36	1.35
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	41.13	3.69
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	43.87	3.53
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	17.29	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	40.29	3.41
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	43.77	2.90
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	20.84	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	40.79	4.50
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	39.10	6.05
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	38.93	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	35.16	3.05
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	38.80	3.56
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	17.10	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	27.43	2.65
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	39.13	2.66
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	13.16	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	30.35	3.40
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	23.02	0.92
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	27.12	2.38
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	20.12	1.68
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	33.95	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	26.34	1.76
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	29.00	2.85
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	12.16	1.11
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	21.18	2.07
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	29.66	3.79
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	22.83	2.45
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	29.61	2.79
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	25.12	2.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	10.32	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	19.71	1.75
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	15.72	1.01
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	8.28	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	23.65	2.17
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	33.82	2.65
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	4.36	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	20.18	0.48
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	27.62	2.80
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	17.83	1.37
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	36.04	1.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	26.95	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	16.31	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	28.03	3.50
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	22.07	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	16.01	1.92
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	28.51	2.23
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	23.66	3.48
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	28.73	4.42
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	25.30	3.76
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	19.26	3.50
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	13.49	1.78
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	24.97	3.09
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	32.00	2.49
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	15.15	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	30.77	3.62
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	36.73	2.92
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	28.88	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	22.17	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	32.44	5.69
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	18.24	0.97
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	25.14	4.66
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	27.45	1.72
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	10.16	0.64
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	26.96	1.60
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	35.92	3.59
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	19.49	1.13
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	24.21	2.55
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	38.03	4.64
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	18.20	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	27.84	2.27
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	36.13	5.90
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	12.38	1.30
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	22.93	2.65
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	34.31	2.31
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	26.38	0.82
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	27.69	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	26.37	11.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	24.95	1.78
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	42.39	1.31
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	26.30	2.10
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	32.62	1.98
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	30.73	0.93
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	33.42	6.01
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	29.56	1.33
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	38.68	2.49
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	28.00	1.47
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	32.98	2.20
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	31.11	3.11
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	41.15	3.74
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	30.91	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	27.27	4.04
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	24.46	2.95
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	28.60	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	17.80	3.18
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	26.72	2.43
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	12.08	1.51
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	57.10	5.71
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	55.46	3.26
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	33.27	4.75
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	37.65	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	28.44	3.23
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	27.70	1.57
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	6.01	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	7.10	2.09
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	13.69	2.66
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	19.15	4.79
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	7.48	2.04
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	25.73	12.86
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	10.04	1.67
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	12.09	1.63
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	11.89	0.54
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	18.29	2.10
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	66.81	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	14.89	0.99
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	9.74	1.08
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	9.75	2.04
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	9.96	3.76
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	20.05	2.92
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	11.14	0.53
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	7.20	2.40
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	20.02	1.97
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	10.73	2.11
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	22.05	1.94
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	7.03	3.52
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	8.73	0.92
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	8.68	2.25
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	17.24	4.14
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	65.74	10.11
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	22.50	2.90
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	9.31	3.81
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	9.26	1.66
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	12.88	3.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	117.36	9.03
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	14.33	3.67
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	16.68	0.90
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	13.09	3.17
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	5.57	1.86
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	16.27	1.51
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	14.66	3.26
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	7.41	1.31
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	24.42	3.62
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	7.06	3.53
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	14.63	1.99
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	14.39	4.96
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	9.19	2.30
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	20.57	0.91
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	25.86	0.88
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	11.52	1.36
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	56.20	25.55
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	18.29	3.66
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	9.44	2.52
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	9.68	0.30
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	10.28	3.96
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	21.54	3.40
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	70.81	0.00
Myoblast, donor1	11241-116D8	26.83	3.98
Myoblast, donor2	11322-117D8	46.41	4.60
Myoblast, donor3	11398-118D3	26.74	4.71
NK T cell leukemia cell line:KHYG-1	10777-110G3	194.53	12.11
Natural Killer Cells, donor1	11230-116C6	49.51	6.77
Natural Killer Cells, donor2	11311-117C6	46.44	5.73
Natural Killer Cells, donor3	11387-118C1	48.96	4.05
Neural stem cells, donor1	11275-116H6	36.66	6.90
Neural stem cells, donor2	11352-117H2	55.84	3.85
Neurons, donor1	11494-119E9	72.83	10.24
Neurons, donor2	11574-120E8	42.05	3.30
Neurons, donor3	11655-122E8	27.13	4.11
Neutrophils, donor1	11233-116C9	36.19	2.78
Neutrophils, donor2	11314-117C9	14.49	0.00
Neutrophils, donor3	11390-118C4	48.87	3.67
Nucleus Pulposus Cell, donor1	11252-116F1	52.36	5.46
Nucleus Pulposus Cell, donor2	11409-118E5	36.14	2.93
Nucleus Pulposus Cell, donor3	11462-119B4	33.69	3.81
Olfactory epithelial cells, donor1	11933-125I7	21.20	2.75
Olfactory epithelial cells, donor2	11934-125I8	17.66	1.74
Olfactory epithelial cells, donor3	11935-125I9	18.73	1.59
Olfactory epithelial cells, donor4	11936-126A1	27.56	2.63
Oligodendrocyte - precursors, donor1	11496-119F2	48.75	3.61
Osteoblast - differentiated, donor1	11276-116H7	24.46	2.77
Osteoblast - differentiated, donor2	11353-117H3	16.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	33.52	2.48
Osteoblast, donor1	11277-116H8	19.35	3.71
Osteoblast, donor2	11354-117H4	20.37	2.81
Osteoblast, donor3	11426-118G4	23.99	3.91
Pancreatic stromal cells, donor1	11249-116E7	35.46	3.12
Pericytes, donor1	11491-119E6	5.34	0.45
Pericytes, donor2	11571-120E5	9.28	0.68
Pericytes, donor3	11652-122E5	17.70	1.83
Perineurial Cells, donor1	11499-119F5	37.30	3.73
Perineurial Cells, donor2	11579-120F4	40.67	4.78
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	64.70	4.14
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	37.95	2.20
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	45.81	2.20
Placental Epithelial Cells, donor1	11278-116H9	16.74	0.72
Placental Epithelial Cells, donor2	11355-117H5	26.61	0.00
Placental Epithelial Cells, donor3	11427-118G5	21.99	1.37
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	17.09	2.85
Preadipocyte - breast, donor1	11467-119B9	23.64	3.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	26.24	2.74
Preadipocyte - breast, donor2	11328-117E5	26.12	4.28
Preadipocyte - omental, donor1	11468-119C1	27.07	2.88
Preadipocyte - omental, donor2	11329-117E6	30.99	4.36
Preadipocyte - omental, donor3	11403-118D8	31.08	3.15
Preadipocyte - perirenal, donor1	11469-119C2	18.70	2.95
Preadipocyte - subcutaneous, donor1	11279-116I1	20.88	2.76
Preadipocyte - subcutaneous, donor2	11356-117H6	32.05	7.44
Preadipocyte - subcutaneous, donor3	11428-118G6	27.25	5.62
Preadipocyte - visceral, donor1	11280-116I2	33.07	5.68
Preadipocyte - visceral, donor2	11357-117H7	24.85	5.98
Preadipocyte - visceral, donor3	11429-118G7	21.21	3.97
Prostate Epithelial Cells (polarized), donor1	11253-116F2	42.24	8.00
Prostate Epithelial Cells, donor2	11331-117E8	30.06	3.93
Prostate Epithelial Cells, donor3	11404-118D9	46.05	1.65
Prostate Stromal Cells, donor1	11254-116F3	29.50	3.30
Prostate Stromal Cells, donor2	11332-117E9	29.76	3.77
Prostate Stromal Cells, donor3	11405-118E1	32.43	3.13
Renal Cortical Epithelial Cells, donor1	11516-119H4	12.41	1.09
Renal Cortical Epithelial Cells, donor2	11596-120H3	35.56	2.15
Renal Epithelial Cells, donor1	11517-119H5	14.20	1.01
Renal Epithelial Cells, donor2	11597-120H4	6.40	0.00
Renal Epithelial Cells, donor3	11678-122H4	45.31	2.43
Renal Glomerular Endothelial Cells, donor1	11514-119H2	10.21	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	17.92	0.81
Renal Glomerular Endothelial Cells, donor3	11675-122H1	48.62	2.66
Renal Glomerular Endothelial Cells, donor4	11783-124B1	8.65	0.00
Renal Mesangial Cells, donor1	11518-119H6	11.88	0.88
Renal Mesangial Cells, donor2	11598-120H5	11.29	1.25
Renal Mesangial Cells, donor3	11679-122H5	8.88	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	24.43	1.07
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	18.55	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	16.58	0.39
Retinal Pigment Epithelial Cells, donor0	11215-116A9	45.63	1.04
Retinal Pigment Epithelial Cells, donor1	11528-119I7	24.16	1.71
Retinal Pigment Epithelial Cells, donor2	11608-120I6	6.17	1.03
Retinal Pigment Epithelial Cells, donor3	11689-122I6	40.65	3.01
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	65.08	1.74
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	72.37	17.87
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	42.93	17.06
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	67.87	11.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	57.34	7.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	55.61	7.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	75.40	12.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	73.56	7.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	61.54	7.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	91.30	14.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	53.12	6.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	65.96	8.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	70.78	11.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	53.51	7.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	59.56	7.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	69.70	13.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	39.38	5.93
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	57.57	6.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	73.66	13.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	52.95	6.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	58.79	7.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	74.66	11.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	51.90	5.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	54.94	5.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	70.58	9.06
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	51.42	5.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	57.76	8.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	78.58	9.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	43.64	6.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	53.57	8.93
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	74.36	12.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	39.19	5.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	56.63	9.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	59.53	11.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	48.18	7.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	49.39	9.03
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	60.54	13.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	47.80	4.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	47.60	8.92
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	58.44	11.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	49.25	5.97
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	77.23	11.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	61.57	10.93
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	61.11	11.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	80.48	16.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	87.87	13.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	59.24	11.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	93.63	19.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	74.34	19.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	58.75	12.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	111.35	33.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	82.14	13.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	59.98	11.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	85.27	17.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	105.44	18.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	69.07	12.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	80.47	17.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	82.33	19.23
Schwann Cells, donor1	11498-119F4	8.09	0.38
Schwann Cells, donor2	11578-120F3	27.22	0.00
Schwann Cells, donor3	11659-122F3	24.10	3.94
Sebocyte, donor1	11220-116B5	38.89	7.12
Sebocyte, donor2	11301-117B5	25.74	6.89
Sebocyte, donor3	11378-118B1	28.65	1.24
Sertoli Cells, donor1	11255-116F4	31.48	1.66
Sertoli Cells, donor2	11333-117F1	19.77	2.82
Skeletal Muscle Cells, donor1	11281-116I3	33.34	2.82
Skeletal Muscle Cells, donor2	11358-117H8	18.79	2.17
Skeletal Muscle Cells, donor3	11430-118G8	19.23	2.51
Skeletal Muscle Cells, donor4	11451-119A2	34.56	3.93
Skeletal Muscle Cells, donor5	11455-119A6	33.45	3.86
Skeletal Muscle Cells, donor6	11459-119B1	30.32	4.77
Skeletal Muscle Satellite Cells, donor1	11240-116D7	51.41	4.03
Skeletal Muscle Satellite Cells, donor2	11321-117D7	47.66	4.71
Skeletal Muscle Satellite Cells, donor3	11397-118D2	38.49	7.34
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	31.76	5.31
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	26.06	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	16.65	3.85
Skin - palm, donor1	10286-104F7	88.64	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	20.47	3.75
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	104.69	12.27
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	22.46	3.12
Small Airway Epithelial Cells, donor1	11256-116F5	56.30	7.92
Small Airway Epithelial Cells, donor2	11334-117F2	43.18	3.38
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	76.54	9.09
Small Airway Epithelial Cells, donor3	11406-118E2	52.47	4.12
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	20.68	1.54
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	20.01	1.11
Smooth Muscle Cells - Aortic, donor0	11210-116A4	27.63	3.53
Smooth Muscle Cells - Aortic, donor1	11283-116I5	14.81	3.76
Smooth Muscle Cells - Aortic, donor2	11360-117I1	21.26	1.97
Smooth Muscle Cells - Aortic, donor3	11432-118H1	21.63	1.55
Smooth Muscle Cells - Bladder, donor1	11519-119H7	51.04	3.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	27.01	1.73
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	34.58	3.32
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	40.59	2.69
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	28.65	6.51
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	31.60	4.43
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	37.30	2.28
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	6.18	0.65
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	53.28	2.13
Smooth Muscle Cells - Carotid, donor1	11285-116I7	31.07	3.03
Smooth Muscle Cells - Carotid, donor2	11362-117I3	91.81	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	15.26	1.91
Smooth Muscle Cells - Colonic, donor1	11239-116D6	22.71	2.65
Smooth Muscle Cells - Colonic, donor2	11320-117D6	32.07	3.01
Smooth Muscle Cells - Colonic, donor3	11396-118D1	30.44	3.25
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	21.35	1.86
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	20.48	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	19.72	1.20
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	8.19	0.34
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	51.44	2.43
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	36.73	2.21
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	42.55	4.10
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	18.72	2.42
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	38.15	3.71
Smooth Muscle Cells - Prostate, donor1	11257-116F6	27.83	2.13
Smooth Muscle Cells - Prostate, donor2	11335-117F3	26.42	3.26
Smooth Muscle Cells - Prostate, donor3	11465-119B7	28.41	2.03
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	25.93	3.92
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	27.76	3.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	10.34	1.29
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	25.11	1.40
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	25.75	1.01
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	25.70	0.94
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	9.14	0.29
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	30.57	2.75
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	33.64	2.34
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	24.61	2.16
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	29.83	2.04
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	13.54	1.13
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	32.42	2.24
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	34.35	2.93
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	11.43	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	29.11	0.73
Smooth Muscle Cells - Uterine, donor1	11258-116F7	24.53	3.98
Smooth Muscle Cells - Uterine, donor3	11466-119B8	25.75	2.05
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	25.66	1.55
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	15.34	2.12
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	16.37	2.60
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	29.11	1.80
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	24.42	1.70
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	19.30	1.97
Smooth muscle cells - airway, control, donor1	11966-126D4	18.79	3.05
Smooth muscle cells - airway, control, donor2	11967-126D5	35.54	1.60
Smooth muscle cells - airway, control, donor3	11968-126D6	23.83	2.51
Smooth muscle cells - airway, control, donor4	11969-126D7	31.17	2.29
Synoviocyte, donor1	11291-117A4	25.92	3.87
Synoviocyte, donor2	11368-117I9	26.48	2.68
Synoviocyte, donor3	11440-118H9	27.48	3.13
Trabecular Meshwork Cells, donor1	11532-120A2	11.08	1.07
Trabecular Meshwork Cells, donor2	11612-122A1	7.93	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	14.12	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	39.64	3.44
Tracheal Epithelial Cells, donor2	11369-118A1	20.87	0.39
Tracheal Epithelial Cells, donor3	11441-118I1	25.20	3.44
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	66.93	1.72
Urethra, donor2	10319-105A4	55.75	0.00
Urothelial Cells, donor1	11520-119H8	8.50	0.27
Urothelial Cells, donor2	11600-120H7	12.02	0.40
Urothelial Cells, donor3	11681-122H7	11.23	0.00
Urothelial cells, donor0	11216-116B1	49.26	1.78
Whole blood (ribopure), donor090309, donation1	12179-129A1	74.74	2.67
Whole blood (ribopure), donor090309, donation2	12180-129A2	81.49	2.86
Whole blood (ribopure), donor090309, donation3	12181-129A3	65.71	2.05
Whole blood (ribopure), donor090325, donation1	12176-128I7	66.46	1.03
Whole blood (ribopure), donor090325, donation2	12177-128I8	61.01	2.91
Whole blood (ribopure), donor090612, donation1	12182-129A4	71.85	1.04
Whole blood (ribopure), donor090612, donation2	12183-129A5	69.75	1.84
Whole blood (ribopure), donor090612, donation3	12184-129A6	63.90	4.56
Wilms' tumor cell line:G-401	10809-111A8	46.01	9.87
Wilms' tumor cell line:HFWT	10597-108E3	38.72	4.40
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	33.80	5.59
achilles tendon, donor2	10292-104G4	74.40	4.13
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	54.31	9.18
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	50.15	7.89
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	76.21	8.55
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	54.15	8.98
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	170.06	30.92
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	56.89	13.11
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	65.06	4.90
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	60.37	5.29
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	63.30	5.72
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	72.22	14.76
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	26.68	1.29
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	50.71	15.60
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	66.93	22.08
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	126.34	13.20
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	112.22	11.40
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	62.74	4.18
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	42.36	0.82
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	22.41	2.15
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	61.02	8.96
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	66.42	5.46
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	67.88	6.26
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	48.11	2.23
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	58.37	2.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	16.72	20.44
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	46.71	5.27
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	57.57	16.57
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	43.11	7.50
adenocarcinoma cell line:IM95m	10796-110I4	42.15	4.71
adipose tissue, adult, pool1	10010-101C1	61.74	2.33
adipose, donor1	10184-103D4	86.79	12.31
adipose, donor2	10185-103D5	37.31	7.30
adipose, donor3	10186-103D6	60.72	6.81
adipose, donor4	10187-103D7	123.95	5.20
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	59.81	7.58
adrenal gland, adult, pool1	10081-102A9	18.19	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	64.97	3.34
alveolar cell carcinoma cell line:SW 1573	10708-109H6	26.44	1.79
amniotic membrane cells, donor1	12235-129G3	36.63	0.46
amniotic membrane cells, donor2	12236-129G4	61.53	2.70
amniotic membrane cells, donor3	12237-129G5	37.71	0.29
amygdala - adult, donor10196	10167-103B5	43.87	2.37
amygdala, adult, donor10252	10151-102I7	81.51	3.65
amygdala, newborn, donor10223	10360-105E9	35.18	1.29
anaplastic carcinoma cell line:8305C	10428-106D5	34.00	1.27
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	61.33	7.50
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	54.45	7.35
aorta, adult, pool1	10052-101G7	27.65	1.37
appendix, adult	10189-103D9	67.92	1.94
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	74.29	3.78
artery, adult	10190-103E1	73.37	0.00
astrocytoma cell line:TM-31	10425-106D2	62.44	4.20
b cell line:RPMI1788	10427-106D4	48.18	4.46
basal cell carcinoma cell line:TE 354.T	10702-109G9	31.63	3.33
bile duct carcinoma cell line:HuCCT1	10432-106D9	55.77	3.37
bile duct carcinoma cell line:TFK-1	10496-107C1	46.70	2.51
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	110.17	2.24
bladder, adult, pool1	10011-101C2	57.91	2.17
blood, adult, pool1	10053-101G8	24.36	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	15.41	5.14
bone marrow, adult	10192-103E3	50.61	4.05
brain, adult, donor1	10084-102B3	38.95	1.03
brain, adult, pool1	10012-101C3	55.01	2.34
brain, fetal, pool1	10085-102B4	45.41	2.67
breast carcinoma cell line:MCF7	10482-107A5	17.84	0.66
breast carcinoma cell line:MDA-MB-453	10419-106C5	33.58	0.37
breast, adult, donor1	10080-102A8	31.57	1.89
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	37.22	6.22
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	41.13	2.16
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	20.95	5.53
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	263.39	29.29
carcinoid cell line:NCI-H1770	10703-109H1	47.96	5.17
carcinoid cell line:NCI-H727	10735-110B6	45.94	1.75
carcinoid cell line:SK-PN-DW	10719-109I8	63.38	1.27
carcinosarcoma cell line:JHUCS-1	10642-109A3	49.24	12.24
caudate nucleus - adult, donor10196	10177-103C6	59.87	2.30
caudate nucleus, adult, donor10252	10164-103B2	72.45	4.52
caudate nucleus, adult, donor10258	10379-105H1	43.56	3.82
caudate nucleus, newborn, donor10223	10354-105E3	49.08	3.30
cerebellum - adult, donor10196	10173-103C2	64.09	5.83
cerebellum, adult, donor10252	10166-103B4	93.94	2.35
cerebellum, adult, pool1	10083-102B2	40.36	2.41
cerebellum, newborn, donor10223	10357-105E6	73.07	2.49
cerebral meninges, adult	10188-103D8	48.66	1.76
cerebrospinal fluid, donor2	10294-104G6	62.86	2.92
cervical cancer cell line:D98-AH2	10552-107I3	46.73	1.87
cervical cancer cell line:ME-180	10553-107I4	34.63	4.64
cervix, adult, pool1	10013-101C4	62.78	4.30
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	20.20	2.23
chondrosarcoma cell line:SW 1353	10700-109G7	22.21	1.31
choriocarcinoma cell line:BeWo	10423-106C9	61.77	1.62
choriocarcinoma cell line:SCH	10785-110H2	23.90	1.36
choriocarcinoma cell line:T3M-3	10618-108G6	41.27	0.95
chorionic membrane cells, donor1	12238-129G6	51.86	3.42
chorionic membrane cells, donor2	12239-129G7	42.76	4.37
chorionic membrane cells, donor3	12240-129G8	67.04	4.40
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	78.76	12.12
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	114.30	10.76
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	61.24	12.04
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	50.85	2.57
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	54.42	3.39
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	58.64	3.26
chronic myelogenous leukemia cell line:K562	10454-106G4	47.11	5.89
chronic myelogenous leukemia cell line:KU812	10409-106B4	137.87	9.38
clear cell carcinoma cell line:JHOC-5	10638-108I8	70.63	4.80
clear cell carcinoma cell line:TEN	10636-108I6	58.82	3.12
colon carcinoma cell line:CACO-2	10513-107D9	51.07	10.43
colon carcinoma cell line:COLO-320	10420-106C6	68.79	2.28
colon, adult, donor1	10082-102B1	26.18	2.38
colon, adult, pool1	10014-101C5	61.81	1.06
colon, fetal, donor1	10070-101I7	50.06	2.47
common myeloid progenitor CMP, donor1	12130-128D6	96.25	0.00
common myeloid progenitor CMP, donor2	12134-128E1	75.11	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	65.44	7.22
cord blood derived cell line:COBL-a 24h infection	10453-106G3	36.68	10.26
cord blood derived cell line:COBL-a untreated	10449-106F8	41.32	6.49
corpus callosum, adult, pool1	10042-101F6	125.93	4.75
cruciate ligament, donor2	10295-104G7	55.11	0.00
diaphragm, fetal, donor1	10069-101I6	44.94	0.80
diencephalon, adult	10193-103E4	102.00	4.32
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	36.97	3.90
ductal cell carcinoma cell line:KLM-1	10438-106E6	49.49	2.31
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	52.96	8.43
ductus deferens, adult	10196-103E7	66.28	1.99
duodenum, fetal, donor1, tech_rep1	10071-101I8	30.24	2.88
duodenum, fetal, donor1, tech_rep2	10071-101I8	73.56	5.15
dura mater, adult, donor1	10041-101F5	50.96	2.89
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	55.52	7.11
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	31.52	4.87
embryonic pancreas cell line:1B2C6	10604-108F1	22.20	1.23
embryonic pancreas cell line:1C3D3	10605-108F2	36.93	1.51
embryonic pancreas cell line:1C3IKEI	10606-108F3	29.02	4.01
embryonic pancreas cell line:2C6	10603-108E9	42.03	5.25
endometrial carcinoma cell line:OMC-2	10497-107C2	58.99	8.04
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	50.38	5.07
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	43.58	2.25
epidermoid carcinoma cell line:A431	10426-106D3	47.02	6.89
epidermoid carcinoma cell line:Ca Ski	10431-106D8	57.08	4.84
epididymis, adult	10197-103E8	56.51	1.67
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	26.79	2.66
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	24.77	4.33
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	56.88	5.11
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	65.65	5.12
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	55.45	6.95
esophagus, adult, pool1	10015-101C6	59.88	1.91
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	45.84	6.76
eye - muscle inferior rectus, donor1	10272-104E2	89.34	4.83
eye - muscle lateral, donor2	10298-104H1	54.71	4.21
eye - muscle medial, donor2	10299-104H2	50.60	0.00
eye - muscle superior, donor2	10297-104G9	52.74	2.29
eye - vitreous humor, donor1	10268-104D7	55.38	2.91
eye, fetal, donor1	10054-101G9	59.24	4.07
fibrosarcoma cell line:HT-1080	10758-110E2	20.90	3.21
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	39.17	3.80
frontal lobe, adult, pool1	10040-101F4	63.80	3.85
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	61.85	4.20
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	37.95	2.74
gall bladder, adult	10198-103E9	43.22	2.41
gamma delta positive T cells, donor1	11937-126A2	93.41	5.91
gamma delta positive T cells, donor2	11938-126A3	68.35	9.71
gastric adenocarcinoma cell line:MKN1	10614-108G2	22.39	5.07
gastric adenocarcinoma cell line:MKN45	10612-108F9	35.40	1.35
gastric cancer cell line:AZ521	10549-107H9	50.83	12.30
gastric cancer cell line:GSS	10560-108A2	76.88	1.83
gastrointestinal carcinoma cell line:ECC12	10615-108G3	57.34	3.66
giant cell carcinoma cell line:LU65	10487-107B1	62.53	1.72
giant cell carcinoma cell line:Lu99B	10433-106E1	46.61	2.10
glassy cell carcinoma cell line:HOKUG	10688-109F4	17.21	1.50
glioblastoma cell line:A172, tech_rep1	10444-106F3	33.57	3.48
glioblastoma cell line:A172, tech_rep2	10444-106F3	29.35	4.63
glioblastoma cell line:T98G	10485-107A8	28.70	4.64
glioma cell line:GI-1	10413-106B8	77.32	9.96
globus pallidus - adult, donor10196	10175-103C4	76.54	0.73
globus pallidus, adult, donor10252	10161-103A8	131.32	4.15
globus pallidus, adult, donor10258	10367-105F7	109.54	9.58
globus pallidus, newborn, donor10223	10364-105F4	64.48	4.80
granulocyte macrophage progenitor, donor1	12131-128D7	63.63	2.45
granulocyte macrophage progenitor, donor2	12135-128E2	10.93	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	20.91	5.23
granulosa cell tumor cell line:KGN	10624-108H3	30.40	3.20
hIPS +CCl2, biol_rep1	14383-156B9	47.75	1.38
hIPS +CCl2, biol_rep2	14384-156C1	51.21	3.66
hIPS +CCl2, biol_rep3	14385-156C2	47.66	5.15
hIPS, biol_rep1	14380-156B6	30.18	4.31
hIPS, biol_rep2	14381-156B7	46.64	3.43
hIPS, biol_rep3	14382-156B8	92.69	1.10
hairy cell leukemia cell line:Mo	10712-109I1	33.62	3.74
heart - mitral valve, adult	10205-103F7	48.13	2.39
heart - pulmonic valve, adult	10206-103F8	59.09	3.40
heart - tricuspid valve, adult	10207-103F9	94.09	1.67
heart, adult, diseased post-infarction, donor1	10050-101G5	25.71	3.06
heart, adult, diseased, donor1	10051-101G6	30.23	1.28
heart, adult, pool1	10016-101C7	78.42	1.61
heart, fetal, pool1	10046-101G1	65.61	3.80
hepatic mesenchymal tumor cell line:LI90	10778-110G4	23.14	1.85
hepatoblastoma cell line:HuH-6	10633-108I3	71.35	3.57
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	43.09	5.19
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	45.64	5.46
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	43.35	6.27
hepatoma cell line:Li-7	10484-107A7	59.06	3.11
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	41.81	4.32
hippocampus - adult, donor10196	10169-103B7	36.91	1.89
hippocampus, adult, donor10252	10153-102I9	95.31	2.25
hippocampus, adult, donor10258	10374-105G5	43.32	1.00
hippocampus, newborn, donor10223	10363-105F3	37.01	3.52
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	57.98	3.05
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	39.47	4.71
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	49.26	4.06
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	56.95	7.33
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	48.80	4.13
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	72.51	5.69
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	57.51	12.55
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	57.73	7.76
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	65.06	9.59
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	59.91	5.45
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	40.02	8.04
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	59.92	8.08
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	40.53	4.54
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	37.34	4.42
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	45.38	5.24
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	66.06	6.30
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	64.10	7.41
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	62.97	4.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	44.65	6.41
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	42.29	6.37
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	43.23	6.58
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	34.78	5.39
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	32.80	4.64
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	46.63	9.86
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	43.97	5.36
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	51.64	4.85
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	63.29	4.08
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	58.45	3.87
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	50.04	3.80
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	66.88	2.72
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	50.68	7.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	40.51	2.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	57.21	5.64
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	50.11	7.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	47.71	9.09
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	49.40	9.07
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	52.17	4.35
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	55.26	6.68
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	57.07	7.32
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	71.51	4.28
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	286.29	29.28
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	93.66	8.27
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	62.39	6.57
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	58.26	6.51
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	63.35	9.96
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	33.41	4.77
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	56.61	6.50
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	35.02	5.12
immature langerhans cells, donor1	11904-125F5	29.06	4.60
immature langerhans cells, donor2	11905-125F6	51.49	5.54
insula, adult, pool1	10039-101F3	51.29	2.27
keratoacanthoma cell line:HKA-1	10791-110H8	25.36	5.53
kidney, adult, pool1	10017-101C8	43.15	3.30
kidney, fetal, pool1	10045-101F9	49.02	2.62
large cell lung carcinoma cell line:IA-LM	10509-107D5	113.76	10.65
large cell lung carcinoma cell line:NCI-H460	10839-111E2	16.59	2.35
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	58.54	2.75
left atrium, adult, donor1	10079-102A7	27.24	1.63
left ventricle, adult, donor1	10078-102A6	41.46	2.53
leiomyoblastoma cell line:G-402	10721-110A1	33.11	8.21
leiomyoma cell line:10964C	10569-108B2	22.27	1.80
leiomyoma cell line:15242A	10570-108B3	20.11	1.63
leiomyoma cell line:15425	10571-108B4	25.50	2.91
leiomyosarcoma cell line:Hs 5.T	10722-110A2	31.75	6.35
lens epithelial cell line:SRA 01/04	10647-109A8	36.59	1.05
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	122.43	9.80
liposarcoma cell line:KMLS-1	10782-110G8	35.62	4.37
liposarcoma cell line:SW 872	10726-110A6	29.36	8.29
liver, adult, pool1	10018-101C9	39.87	1.78
liver, fetal, pool1	10086-102B5	19.75	0.00
locus coeruleus - adult, donor10196	10182-103D2	70.72	2.33
locus coeruleus, adult, donor10252	10165-103B3	105.01	4.61
locus coeruleus, adult, donor10258	10375-105G6	59.53	5.64
locus coeruleus, newborn, donor10223	10362-105F2	47.11	5.89
lung adenocarcinoma cell line:A549	10499-107C4	30.59	2.63
lung adenocarcinoma cell line:PC-14	10408-106B3	13.79	1.38
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	65.64	5.27
lung, adult, pool1	10019-101D1	45.60	1.54
lung, fetal, donor1	10068-101I5	89.62	3.42
lung, right lower lobe, adult, donor1	10075-102A3	54.99	6.42
lymph node, adult, donor1	10077-102A5	35.03	1.89
lymphangiectasia cell line:DS-1	10727-110A7	44.93	0.66
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	22.94	3.77
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	34.83	4.25
mature adipocyte, donor1	12231-129F8	80.36	4.00
mature adipocyte, donor2	12232-129F9	66.62	2.28
mature adipocyte, donor3	12233-129G1	81.31	2.84
mature adipocyte, donor4	12234-129G2	85.28	3.16
maxillary sinus tumor cell line:HSQ-89	10414-106B9	91.73	4.77
medial frontal gyrus - adult, donor10196	10170-103B8	45.12	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	76.14	2.21
medial frontal gyrus, adult, donor10258	10368-105F8	42.25	0.95
medial frontal gyrus, newborn, donor10223	10352-105E1	36.25	2.56
medial temporal gyrus - adult, donor10196	10183-103D3	41.85	1.69
medial temporal gyrus, adult, donor10252	10156-103A3	87.01	1.70
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	50.08	3.85
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	86.12	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	26.56	2.87
medulla oblongata - adult, donor10196	10174-103C3	68.79	3.89
medulla oblongata, adult, donor10252	10155-103A2	103.41	4.02
medulla oblongata, adult, pool1	10038-101F2	79.67	4.57
medulla oblongata, newborn, donor10223	10361-105F1	67.35	3.47
medulloblastoma cell line:D283 Med	10838-111E1	84.58	1.55
medulloblastoma cell line:ONS-76	10759-110E3	33.38	2.81
melanoma cell line:COLO 679	10514-107E1	34.21	5.32
melanoma cell line:G-361	10465-106H6	31.76	6.24
meningioma cell line:HKBMM	10691-109F7	28.94	1.81
merkel cell carcinoma cell line:MKL-1	10843-111E6	37.01	2.64
merkel cell carcinoma cell line:MS-1	10844-111E7	50.55	5.96
mesenchymal precursor cell - adipose, donor1	11747-123G1	35.75	5.98
mesenchymal precursor cell - adipose, donor2	11748-123G2	35.45	4.36
mesenchymal precursor cell - adipose, donor3	11749-123G3	29.82	0.83
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	31.75	1.69
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	24.07	2.70
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	34.01	1.39
mesenchymal precursor cell - cardiac, donor1	11752-123G6	23.34	1.37
mesenchymal precursor cell - cardiac, donor2	11753-123G7	27.83	3.22
mesenchymal precursor cell - cardiac, donor3	11754-123G8	31.70	4.38
mesenchymal precursor cell - cardiac, donor4	11755-123G9	26.87	3.11
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	31.01	2.70
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	25.03	0.66
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	34.18	3.74
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	31.77	1.75
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	33.48	1.84
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	25.52	3.59
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	25.66	1.34
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	22.57	3.42
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	31.47	5.45
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	31.38	2.39
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	31.95	2.45
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	35.34	1.84
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	28.04	1.72
mesenchymal stem cell line:Hu5/E18	10568-108B1	23.16	2.95
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	26.03	2.28
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	25.07	1.53
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	38.48	3.40
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	23.72	2.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	26.36	2.59
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	31.81	1.69
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	26.33	3.93
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	22.24	1.85
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	28.84	4.04
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	29.45	1.78
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	23.07	3.61
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	30.80	2.93
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	28.87	3.02
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	26.20	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	36.51	1.72
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	35.55	2.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	10.33	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	20.46	2.60
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	20.37	1.45
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	23.46	4.80
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	11.45	1.64
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	26.43	3.50
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	23.09	2.10
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	17.88	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	17.79	1.78
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	12.18	2.44
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	24.70	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	29.32	1.72
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	47.28	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	39.92	3.99
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	34.44	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	38.30	2.04
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	38.93	2.38
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	31.24	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	42.08	1.56
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	48.12	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	39.03	3.55
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	41.09	5.14
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	42.68	3.44
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	30.18	2.97
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	38.13	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	32.44	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	36.67	1.21
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	37.07	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	46.88	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	47.94	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	22.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	35.42	1.65
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	27.18	1.59
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	27.26	4.22
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	32.60	3.06
mesodermal tumor cell line:HIRS-BM	10696-109G3	30.95	1.55
mesothelioma cell line:ACC-MESO-1	10493-107B7	51.74	4.96
mesothelioma cell line:ACC-MESO-4	10494-107B8	33.59	9.50
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	64.10	4.27
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	26.72	4.73
mesothelioma cell line:Mero-25	10850-111F4	25.65	2.95
mesothelioma cell line:Mero-41	10851-111F5	33.98	3.67
mesothelioma cell line:Mero-48a	10852-111F6	26.79	3.10
mesothelioma cell line:Mero-82	10853-111F7	59.39	10.25
mesothelioma cell line:Mero-83	10854-111F8	53.79	4.43
mesothelioma cell line:Mero-84	10855-111F9	42.21	10.36
mesothelioma cell line:Mero-95	10856-111G1	44.10	8.90
mesothelioma cell line:NCI-H2052	10847-111F1	19.55	1.99
mesothelioma cell line:NCI-H226	10846-111E9	35.11	13.76
mesothelioma cell line:NCI-H2452	10848-111F2	28.01	3.76
mesothelioma cell line:NCI-H28	10845-111E8	32.57	4.33
mesothelioma cell line:No36	10857-111G2	32.95	3.59
mesothelioma cell line:ONE58	10858-111G3	26.28	2.17
migratory langerhans cells, donor1	11901-125F2	30.90	2.11
migratory langerhans cells, donor2	11902-125F3	32.73	2.93
migratory langerhans cells, donor3	11903-125F4	40.20	3.59
mixed mullerian tumor cell line:HTMMT	10689-109F5	37.55	2.29
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	27.55	3.60
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	45.38	2.30
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	25.50	3.23
myelodysplastic syndrome cell line:SKM-1	10772-110F7	86.48	5.91
myeloma cell line:PCM6	10474-106I6	48.63	2.97
myxofibrosarcoma cell line:MFH-ino	10600-108E6	31.96	7.61
myxofibrosarcoma cell line:NMFH-1	10684-109E9	46.88	3.92
nasal epithelial cells, donor1, tech_rep1	12226-129F3	57.72	2.67
nasal epithelial cells, donor1, tech_rep2	12226-129F3	52.95	1.47
nasal epithelial cells, donor2	12227-129F4	89.97	7.18
neuroblastoma cell line:CHP-134	10508-107D4	86.04	12.88
neuroblastoma cell line:NB-1	10539-107G8	62.49	8.79
neuroblastoma cell line:NBsusSR	10607-108F4	60.31	3.16
neuroblastoma cell line:NH-12	10555-107I6	111.44	8.76
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	74.49	2.14
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	77.92	11.72
neuroectodermal tumor cell line:TASK1	10774-110F9	36.83	5.64
neuroepithelioma cell line:SK-N-MC	10728-110A8	112.53	5.72
neurofibroma cell line:Hs 53.T	10729-110A9	24.75	2.66
neutrophil PMN, donor1	12133-128D9	44.62	0.00
neutrophil PMN, donor2	12137-128E4	119.53	0.00
neutrophil PMN, donor3	12141-128E8	37.88	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	117.71	16.07
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	99.26	7.20
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	25.33	7.05
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	33.90	2.10
nucleus accumbens, adult, pool1	10037-101F1	55.68	2.16
occipital cortex - adult, donor10196	10172-103C1	55.63	2.06
occipital cortex, adult, donor10252	10163-103B1	111.64	2.42
occipital cortex, newborn, donor10223	10355-105E4	33.48	1.82
occipital lobe, adult, donor1	10076-102A4	55.37	3.41
occipital lobe, fetal, donor1	10073-102A1	63.51	8.15
occipital pole, adult, pool1	10036-101E9	38.87	1.50
olfactory region, adult	10195-103E6	61.52	1.34
optic nerve, donor1	10277-104E7	198.10	6.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	64.13	3.87
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	78.04	10.17
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	27.09	4.23
oral squamous cell carcinoma cell line:SAS	10544-107H4	32.69	3.23
osteoclastoma cell line:Hs 706.T	10704-109H2	26.46	2.94
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	71.01	7.47
osteosarcoma cell line:HS-Os-1	10558-107I9	40.93	8.27
ovary, adult, pool1	10020-101D2	42.19	2.36
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	43.45	3.48
pancreas, adult, donor1	10049-101G4	59.26	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	64.57	3.63
papillary adenocarcinoma cell line:8505C	10437-106E5	33.73	2.56
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	40.07	2.81
paracentral gyrus, adult, pool1	10035-101E8	55.74	2.29
parietal cortex, adult, donor10258	10373-105G4	60.19	2.20
parietal lobe - adult, donor10196	10171-103B9	40.44	1.88
parietal lobe, adult, donor10252	10157-103A4	87.79	2.00
parietal lobe, adult, pool1	10034-101E7	60.27	2.56
parietal lobe, fetal, donor1	10072-101I9	64.98	10.67
parietal lobe, newborn, donor10223	10356-105E5	35.89	2.62
parotid gland, adult	10199-103F1	39.47	1.85
penis, adult	10200-103F2	60.16	3.76
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	159.72	1.67
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	42.83	4.81
pineal gland - adult, donor10196	10179-103C8	54.18	1.29
pineal gland, adult, donor10252	10160-103A7	82.91	1.78
pineal gland, adult, donor10258	10377-105G8	42.64	1.25
pituitary gland - adult, donor10196	10180-103C9	116.36	10.12
pituitary gland, adult, donor10252	10162-103A9	124.56	2.61
pituitary gland, adult, donor10258	10378-105G9	68.95	5.11
placenta, adult, pool1	10021-101D3	66.33	2.90
plasma cell leukemia cell line:ARH-77	10840-111E3	64.49	2.78
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	19.61	1.71
pons, adult, pool1	10033-101E6	81.08	5.94
postcentral gyrus, adult, pool1	10032-101E5	50.04	1.74
promyelocytes/myelocytes PMC, donor1	12132-128D8	83.66	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	38.56	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	35.21	0.00
prostate cancer cell line:DU145	10490-107B4	51.71	6.85
prostate cancer cell line:PC-3	10439-106E7	36.12	3.81
prostate, adult, pool1	10022-101D4	63.57	2.27
putamen, adult, donor10196	10176-103C5	54.29	3.78
putamen, adult, donor10252	10152-102I8	90.19	3.92
putamen, adult, donor10258, tech_rep1	10372-105G3	43.71	1.09
putamen, adult, donor10258, tech_rep2	10372-105G3	39.62	1.93
putamen, newborn, donor10223	10365-105F5	41.23	3.00
rectal cancer cell line:TT1TKB	10469-106I1	67.21	4.07
rectum, fetal, donor1	10067-101I4	52.86	12.52
renal cell carcinoma cell line:OS-RC-2	10411-106B6	20.35	2.33
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	77.46	0.41
retina, adult, pool1	10030-101E3	44.93	1.99
retinoblastoma cell line:Y79	10475-106I7	91.97	5.46
rhabdomyosarcoma cell line:KYM-1	10787-110H4	28.40	7.50
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	75.36	15.75
sacrococcigeal teratoma cell line:HTST	10695-109G2	21.98	0.76
salivary acinar cells, donor1	11771-123I7	47.59	5.18
salivary acinar cells, donor2	11772-123I8	56.86	7.71
salivary acinar cells, donor3	11773-123I9	50.98	0.66
salivary gland, adult, pool1	10093-102C3	36.60	0.57
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	38.36	2.53
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	37.15	3.06
seminal vesicle, adult	10201-103F3	66.66	3.70
serous adenocarcinoma cell line:JHOS-2	10639-108I9	28.67	2.43
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	41.27	2.01
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	35.12	3.01
serous cystadenocarcinoma cell line:HTOA	10693-109F9	71.46	9.13
signet ring carcinoma cell line:Kato III	10436-106E4	60.13	3.98
signet ring carcinoma cell line:NUGC-4	10483-107A6	32.13	3.87
skeletal muscle - soleus muscle, donor1	10282-104F3	73.77	0.71
skeletal muscle, adult, pool1	10023-101D5	77.72	2.04
skeletal muscle, fetal, donor1	10066-101I3	23.12	6.03
skin, adult, donor1	10074-102A2	27.14	0.00
skin, fetal, donor1	10065-101I2	61.86	8.21
small cell cervical cancer cell line:HCSC-1	10800-110I8	72.04	8.67
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	97.71	10.40
small cell lung carcinoma cell line:DMS 144	10841-111E4	212.99	5.01
small cell lung carcinoma cell line:LK-2	10541-107H1	116.04	3.96
small cell lung carcinoma cell line:NCI-H82	10842-111E5	120.48	0.80
small cell lung carcinoma cell line:WA-hT	10562-108A4	53.83	4.36
small intestine, adult, pool1	10024-101D6	62.71	1.55
small intestine, fetal, donor1	10064-101I1	49.14	5.90
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	43.60	3.08
smooth muscle, adult, pool1	10048-101G3	51.69	1.03
somatostatinoma cell line:QGP-1	10781-110G7	31.09	0.54
spinal cord - adult, donor10196	10181-103D1	75.25	8.03
spinal cord, adult, donor10252	10159-103A6	95.02	4.73
spinal cord, adult, donor10258	10369-105F9	117.61	9.69
spinal cord, fetal, donor1	10056-101H2	94.52	11.59
spinal cord, newborn, donor10223	10359-105E8	89.09	7.35
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	21.21	2.09
spleen, adult, pool1	10025-101D7	47.03	2.97
spleen, fetal, pool1	10044-101F8	54.27	2.46
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	50.62	5.69
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	63.42	10.06
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	34.95	6.29
squamous cell carcinoma cell line:T3M-5	10616-108G4	34.40	1.17
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	38.38	1.46
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	35.58	5.08
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	40.61	3.81
stomach, fetal, donor1	10062-101H8	48.06	4.27
submaxillary gland, adult	10202-103F4	55.26	1.71
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	131.89	4.98
substantia nigra, adult, donor10258	10371-105G2	78.10	1.03
substantia nigra, newborn, donor10223	10358-105E7	93.97	9.19
synovial sarcoma cell line:HS-SY-II	10441-106E9	55.94	11.23
temporal lobe, adult, pool1	10031-101E4	36.96	1.78
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	56.27	6.41
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	73.84	2.64
tenocyte, donor1	11763-123H8	33.16	2.09
tenocyte, donor2	11765-123I1	47.31	2.67
tenocyte, donor3	11768-123I4	34.47	2.59
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	71.21	7.65
teratocarcinoma cell line:NCR-G1	10798-110I6	42.39	5.40
teratocarcinoma cell line:PA-1	10807-111A6	59.82	1.86
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	88.74	8.63
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	88.11	3.03
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	84.85	1.96
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	117.25	2.28
testis, adult, pool1	10026-101D8	67.75	3.87
testis, adult, pool2	10096-102C6	75.33	2.26
thalamus - adult, donor10196	10168-103B6	82.80	3.31
thalamus, adult, donor10252	10154-103A1	120.81	3.28
thalamus, adult, donor10258, tech_rep1	10370-105G1	113.93	7.70
thalamus, adult, donor10258, tech_rep2	10370-105G1	39.85	3.46
thalamus, newborn, donor10223	10366-105F6	33.37	3.45
throat, adult	10209-103G2	61.67	2.25
throat, fetal, donor1	10061-101H7	56.98	3.05
thymic carcinoma cell line:Ty-82	10803-111A2	68.56	3.78
thymus, adult, pool1	10027-101D9	67.90	3.38
thymus, fetal, pool1	10043-101F7	86.34	2.18
thyroid carcinoma cell line:KHM-5M	10776-110G2	54.25	4.65
thyroid carcinoma cell line:TCO-1	10783-110G9	49.45	2.10
thyroid, adult, pool1	10028-101E1	71.48	2.15
thyroid, fetal, donor1	10060-101H6	49.57	5.54
tongue epidermis (fungiform papillae), donor1	10288-104F9	67.75	0.00
tongue, adult	10203-103F5	57.45	2.56
tongue, fetal, donor1	10059-101H5	52.81	3.55
tonsil, adult, pool1	10047-101G2	62.51	3.41
trachea, adult, pool1	10029-101E2	49.00	1.64
trachea, fetal, donor1	10058-101H4	47.70	6.16
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	24.09	3.19
transitional-cell carcinoma cell line:5637	10418-106C4	39.31	5.17
transitional-cell carcinoma cell line:JMSU1	10492-107B6	111.09	5.33
tridermal teratoma cell line:HGRT	10694-109G1	39.95	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	44.19	6.77
umbilical cord, fetal, donor1	10057-101H3	18.78	4.17
uterus, adult, pool1	10100-102D1	59.72	2.56
uterus, fetal, donor1	10055-101H1	61.43	9.21
vagina, adult	10204-103F6	63.33	3.23
vein, adult	10191-103E2	86.14	4.60
xeroderma pigentosum b cell line:XPL 17	10563-108A5	45.93	4.81

Property "Nearest transcripts" (as page type) with input value "ENST00000531266.5:-48 BC017029:-54 ENST00000524546.5:-55 AB590505:-63 KJ891191:-63 BT009854:-63 L10413:-69 BC084566:-71 L00634:-77 KJ905747:78 ENST00000533998.5:-79 ENST00000533383.5:-80 ENST00000527153.5:-82 ENST00000302279.8:-87 NM_002027.3:-87 NR_033698.2:-87 AK292121:-87 ENST00000526755.5:-102 BC037295:-102 ENST00000525699.5:136 ENST00000529687.5:217 AK123002:217" contains invalid characters or is incomplete and therefore can cause unexpected results during a query or annotation process.